Bitopertin
disc
[]
$iron announced data from its ongoing phase 2 open-label beacon trial evaluating bitopertin in patients with erythropoietic protoporphyria and x-linked protoporphyria at the eha 2023 congress.
MAISA's Platform is based  MAISA's proprietary Optimization on Mathematical Probability Algorithm (OMPA) which derived majority from applied mathematics.